Minimal residual disease testing could transform cancer care—personalized therapies, early relapse detection, and improved ...

We have found that the use of VIGex categorization of tumor samples pre-treatment and analysis of changes in ctDNA dynamics detected by liquid biopsy improves prediction of response to ...

the researchers programmed SEQUOIA to display the genetic findings as a visual map of the tumor biopsy, letting scientists and clinicians see how genetic variations might be distinct in different ...

While liquid biopsy enables the diagnosis or analysis of tumors using a blood or ... a deep pipeline of well-characterized RNA gene expression tissue tests to make this a reality.” ...

Novel liquid biopsy tools allowing for diagnosis and prognostic prediction for gastric cancer (GC) patients are urgently ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

To determine the type and severity of a cancer ... tumor biopsy, letting scientists and clinicians see how genetic variations might be distinct in different areas of a tumor. To test the utility ...